In ruminants, endometrial prostalgandin (PG) F2alpha causes functional luteolysis, whereas luteal synthesis of PGF 2alpha is required for structural luteolysis. PGE2 is considered to be a luteoprotective mediator. Molecular aspects of luteal PGF2alpha and PGE2 biosynthesis and signaling during the estrous cycle and establishment of pregnancy are largely unknown. The objectives of the present study were 1) to determine the regulation of proteins involved in PGF2alpha and PGE2 biosynthesis, catabolism, transport and signaling in the corpus luteum (CL); 2) to investigate the transport of interferon tau (IFNT), PGF2alpha, and PGE2 from the uterus to the ovary through the vascular uteroovarian plexus (UOP); and 3) to compare the intraluteal production of PGF2alpha and PGE2 on Days 12, 14, and 16 of the estrous cycle and pregnancy in sheep. Our results indicate that luteal PG biosynthesis is selectively directed towards PGF2alpha at the time of luteolysis and towards PGE 2 during the establishment of pregnancy. Moreover, the ability of the CL of early pregnancy to resist luteolysis is due to increased intraluteal biosynthesis of PGE2 and PGE2 receptor (PTGER) 2 (also known as EP2)-and PTGER4 (also known as EP4)-mediated signaling. We also found that IFNT protein is not transported through the UOP from the uterus to the ovary; in contrast, a large proportion of endometrial PGE2 is transported from the uterus to the ovary through the UOP. These results indicate that endometrial PGE2 stimulated by pregnancy is transported locally to the ovary, which increases luteal PGE2 biosynthesis and hence activates luteal PTGER2 and PTGER4 signaling, thus protecting the CL during the establishment of pregnancy in sheep.
INTRODUCTION
Arachidonic acid (AA) is the primary precursor for the synthesis of prostaglandins (PGs). Cytosolic phospholipase A2 liberates AA from phospholipids. Prostaglandin-endoperoxide synthases 1 (PTGS-1) and 2 (PTGS-2) (also known as cyclooxygenases COX-1 and COX-2, respectively) convert AA into PGH 2 [1] . Prostaglandin F synthases PTGFS-AKR1B1 (earlier known as AKR1B5) and PTGFS-AKR1C3 convert PGH 2 into PGF 2a . Prostaglandin E synthases PTGES-1 (microsomal PGES-1), PTGES-2 (microsomal PGES-2), and PTGES-3 (cytosolic PGES) convert PGH 2 into PGE 2 . Prostaglandin dehydrogenase (PGDH) catabolizes PGF 2a and PGE 2 into inactive metabolites 13,14-dihydro-15-keto-prostaglandin F 2a (PGFM) and 13,14-dihydro-15-keto prostaglandin E 2 (PGEM), respectively [2] . PGF 2a and PGE 2 are transported competitively across cell membranes by solute carrier organic anion transporter family, member 2A1 (SLCO2A1; also known as prostaglandin transporter [PGT] ) [3] . PGF 2a and PGE 2 exert their biological effects via seven-transmembrane G proteincoupled receptors [4] . PGF 2a acts through PGF 2a receptor (PTGFR, also known as FP), and activation of PTGFR in turn activates protein kinase C (PKC) and Ca2 þ cell signaling pathways [4] . Multifaceted effects of PGE 2 are meditated through PGE 2 receptor (PTGER) 1, PTGER2, PTGER3, and PTGER4 (also known as EP1, EP2, EP3, and EP4, respectively) by integrating multiple cell signaling pathways [5, 6] . PTGER1 activates PKC and Ca2 þ pathways. PTGER2 and PTGER4 activate the protein kinase A (PKA) pathway. Activation of PTGER3A through PTGER3D produces a wide range of complex and opposite actions [4] . Recent studies indicate that PGE 2 transactivates extracellular signal-regulated kinases (ERK1/2), AKT (also known as protein kinase B; PKB), nuclear factor-kappa B (NFjB), and b-catenin (CTNNB1) pathways through EP2 and EP4 in cancer [5, 6] and in endometriosis [7] .
In ruminants, PGF 2a is the luteolytic hormone, whereas PGE 2 is considered to be a luteoprotective mediator [8] [9] [10] . At the time of natural luteolysis in ruminants, PGF 2a is released in a pulsatile manner from the endometrium. A minimum of five 1-h pulses of PGF 2a over a period of 48 h is required to cause complete functional (decline in progesterone) as well as structural (loss of luteal cells) luteolysis consistently in sheep [11] . Systemic administration of PGF 2a during the midluteal phase of the estrous cycle in sheep increases luteal PGF 2a production, which is inhibited by pretreatment with indomethacin, as measured in corpus luteum (CL) explant culture [12] . In sheep, administration of a luteolytic dose of PGF 2a in vivo and treatment of luteal cells with PGF 2a in vitro induces expression of PTGS-2 mRNA in luteal tissues/cells [13] [14] [15] . These findings suggest that endometrial PGF 2a causes functional luteolysis and that luteal synthesis of PGF 2a likely is an important component of a positive-feedback loop between the uterus and the CL during the process of structural luteolysis [16] .
In ruminants, the CL of early pregnancy is more resistant to the luteolytic action of PGF 2a [17] [18] [19] [20] [21] on , and the resistance is even greater when multiple embryos are present [18] . Injection of PGF 2a into an ovarian artery or follicles of early pregnant sheep caused luteolysis in 28% and 17% of animals, compared with 78% and 83% in nonpregnant sheep, respectively [17, 19] . Exogenous estradiol at doses causing premature luteolysis in cyclic sheep is less effective in pregnant sheep [22] . Intraovarian administration of PGE 2 counteracts the luteolytic actions of PGF 2a [23] . PGE 2 is secreted by both the conceptus [24] [25] [26] and the endometrium [26] [27] [28] from pregnant ewes in vitro. Intrauterine or intraovarian infusions of PGE 2 in nonpregnant ewes extends the interestrous interval and reduces luteal sensitivity to both endogenously secreted and exogenously administered PGF 2a [19, 23, [29] [30] [31] . Overall, the above-mentioned studies provide compelling evidence that, as a component of antiluteolytic mechanisms, PGE 2 produced in the CL may counteract the luteolytic effect of both exogenous and endogenous PGF 2a during early pregnancy in ruminants. However, the underlying molecular and cellular mechanisms are largely unknown.
During the establishment of pregnancy, interferon tau (IFNT) secreted by the trophoblast of the conceptus inhibits endometrial pulsatile release of PGF 2a and prevents luteolysis [32] . Intrauterine infusions of exogenous IFNT in cyclic sheep inhibits endometrial pulses of PGF 2a by suppressing receptors for estrogen (ESR-1) and oxytocin (OXTR) [32] . Infusions of IFNT directly into the uterine vein maintained a functional CL in 80% of sheep for up to 32 days through as-yet-unidentified mechanisms [33, 34] . Experiments involving anastomosis of the uterine vein or the ovarian artery (OA) from the pregnant to the nonpregnant uterine horn indicated that both luteolytic and luteoprotective mediators need to be transported locally from the utero-ovarian vein (UOV) to the OA via the utero-ovarian plexus (UOP) in sheep and cattle [35] [36] [37] . Moreover, embryo/ conceptus transfer and hysterectomy experiments indicated that the luteolytic and luteoprotective mechanisms are locally mediated between the uterus and the CL of the ipsilateral ovary and do not act systemically in sheep [38] [39] [40] . Early studies demonstrated that during the establishment of pregnancy in sheep, one or more factors from the conceptus or gravid uterus reach the ovary locally through the UOP and protect the CL from luteolysis [10, 21, 35, 36, [39] [40] [41] [42] . However, such a factor has not been positively identified.
The objectives of the present study were 1) to determine the regulation of proteins involved in PGF 2a and PGE 2 biosynthesis, catabolism, transport and signaling in the CL; 2) to investigate the transport of IFNT, PGF 2a , and PGE 2 from the uterus to the ovary through the UOP; and 3) to compare the intraluteal production of PGF 2a and PGE 2 on Days 12, 14, and 16 of the estrous cycle and pregnancy in sheep.
MATERIALS AND METHODS

Materials
The reagents used in the present study were purchased from the following suppliers: prestained protein markers and Bio-Rad assay reagents and standards (Bio-Rad Laboratories); protran BA83 Nitrocellulose membrane (Whatman, Inc.); Pierce ECL Western blotting substrate (Pierce); protease inhibitor (Roche Applied Biosciences); antibiotic-antimycotic and Trypsin-ethylenediaminetetra-acetic acid (EDTA; Invitrogen Life Technologies, Inc.); rabbit polyclonal anti-human PTGS-1, PTGS-2, PTGES -1, PTGES-2, PTGES-3, PGDH,  PTGFR, PTGER1, PTGER2, PTGER 3, PTGER4, and SLCO2A1 antibodies  and PGF 2a , 
Animal Husbandry and Surgery
Matured crossbred Suffolk ewes (Ovis aries) were observed daily for estrus in the presence of vasectomized rams. Ewes that had exhibited at least two estrous cycles of normal duration (17-18 days) were used in the present study. All experiments and surgical procedures were in accordance with the Guide for Care and Use of Agricultural Animals and approved by Texas A&M University's Laboratory Animal Care and Use Committee.
At estrus (Day 0), the ewes were bred to either an intact or a vasectomized ram. The ewes (n ¼ 4 per day) were randomly ovariohysterectomized on Days 12, 14, or 16 of the estrous cycle and on Days 12, 14, or 16 of pregnancy as described previously [43, 44] . On the day of surgery, a jugular vein was catheterized using a BD Angiocath 16 gauge x 3.25-inch intravenous Teflon catheter. Anesthesia was induced using diazepam (0.2 mg/kg i.v.; Abbott Laboratories) and ketamine (4 mg/kg i.v.; Ketaset; Fort Dodge). The ewes were intubated endotracheally and ventilated spontaneously. Anesthesia was maintained using isoflurane (0.5%-2.5%; IsoFlo; Abbott Laboratories) and oxygen as described previously [45] . A ventral midline laparotomy was performed, and the entire reproductive tract was exteriorized as described previously [45] . Blood samples (5 ml) were collected from the UOV and ovarian vein (OV) ipsilateral to the CL using a 20 gauge butterfly needle. The OA was isolated from the ovarian pedicle by blunt dissection. Each ewe was given heparin (10 000 IU/ewe i.v.) 10 min before the OA was sectioned and blood (5 ml) was collected. Plasma was harvested immediately from all blood samples, and indomethacin (100 lM) was added to prevent in vitro production of PGs. Ringer lactate was administered at the rate of 5 ml kg À1 h À1 to replace fluid losses and to maintain systemic blood pressure. A heating pad was placed underneath the animal and used to maintain body temperature, which was monitored on a continuous basis. At the end of each experiment, the ewes were euthanized using Beuthanasia (MWI Veterinary Supply, Boise, ID).
Ovariohysterectomy was then performed. The uterus was flushed with 20 ml of physiological saline, then centrifuged at 2000 rpm for 10 min, after which the supernatant (uterine flushing [UF]) was collected. Indomethacin (100 lM) was then added to prevent in vitro production of PGs, and the UF samples were stored at À208C until analysis. Pregnancy was confirmed on each day by the presence of a normal conceptus in the uterine lumen flushing as described previously [44] . The uterus was separated from the surrounding tissues and vasculature, and sections (thickness, ;0.5 cm) from the midportion of each uterine horn were fixed in fresh 4% buffered paraformaldehyde and processed for immunohistochemistry using standard procedures. The ovaries were collected, and the CLs were isolated. Two sections from the midportion of each CL were collected: One section was processed for explant culture as described below, and the other section was fixed in fresh 4% buffered paraformaldehyde and processed for immunohistochemistry using standard procedures. The remaining CL tissue was cut into small pieces, snap-frozen in liquid nitrogen, and stored at À808C for protein extraction.
Protein Extraction
Total protein was isolated from CL tissues as described previously [46, 47] . Briefly, tissues were homogenized in buffer (50 1.0% Tween-20) using a Microson ultrasonic cell disruptor (Microsonix Incorporated), then centrifuged at 15 000 3 g for 15 min at 48C, after which the supernatants (total protein) were stored at À808C until analyzed. Total protein concentrations were determined using the Bradford method [48] and a Bio-Rad Protein Assay kit.
Western Blot Analysis
Total protein samples (75 lg) were resolved using 7.5%, 10%, or 12.5% SDS-PAGE, and Western blot analysis was performed as described previously [46, 47] . The blots were incubated with one of the following primary antibody for overnight at 48C: PTGS-1, PTGS-2, PTGES-1, PTGES-2, PTGES-3, AKR1B1-PGFS, AKR1C3-PGFS, PGDH, PTGFR, PTGER1, PTGER2, PTGER4, or SLCO2A1 antibody was used at 1:250 dilution, and b-actin was used at 1:8000 dilution. Then, the blots were washed and incubated with goat anti-rabbit or anti-mouse IgG conjugated with horse radish peroxidase secondary antibody at 1:10 000 dilution for 1 h at room temperature. Chemiluminescent substrate was applied according to the manufacturer's instructions (Pierce Biotechnology). The blots were exposed to Blue X-Ray film, and densitometry of autoradiograms was performed using an Alpha Imager (Alpha Innotech Corporation).
Immunohistochemistry
Paraffin sections (thickness, 5 lm) were used for immunohistochemical localization of the proteins using a Vectastain Elite ABC kit according to the manufacturer's protocols and as described previously [7, 46, 49] . Endogenous peroxidase activity was removed by fixing sections in 0.3% hydrogen peroxide in methanol. Tissue sections were blocked in 10% goat serum for 1 h at room temperature. Incubation with the primary antibodies for PTGS-2, PTGES-1, PTGES-3, PTGFS-AKR1B1, PTGFS-AKR1C3, PGDH, PTGFR, PTGER1, PTGER2, PTGER4, or SLCO2A1 (1:125 dilution) was performed overnight at 48C. The tissue sections were further incubated with the secondary antibody (goat anti-rabbit IgG biotinylated) for 45 min at room temperature. For the negative control, serum or IgG from respective species with reference to the primary antibody at the respective dilution was used.
Digital images were captured using a Zeiss Axioplan 2 Research Microscope (Carl Zeiss) with an Axiocam HR digital color camera. The intensity of staining for each protein was quantified using Image-ProPlus 6.3 image processing and analysis software according to the manufacturer's instructions (Media Cybernetics, Inc.). The detailed methods for quantification are given in the instruction guide, ''The Image-Pro Plus: The proven solution for image analysis.'' In brief, six images of at 4003 magnification were captured randomly without hot-spot bias in each tissue section per animal. Integrated optical density of immunostaining was quantified under RGB mode as published recently [50] . Numerical data were expressed as the least square mean 6 SEM. This technique is more quantitative than conventional blind scoring systems, and the validity of the quantification was reported previously by our group [7, 46, 49, 50] .
CL Explant Culture
The CL tissue (;100 mg) was cut into 1-mm 3 fragments and cultured in 1 ml of plain DMEM/F12 in 5% CO 2 and 95% air at 378C in a 24-well tissueculture plate. At 0 min, PGH 2 at 0, 25, 50, 75, 100, or 200 lg/ml was added. At 90 min, the culture medium was collected, and concentrations of PGF 2a and PGE 2 were measured by ELISA as described below.
Intraluteal PGF 2a and PGE 2 Extraction
Intracellular PGs from luteal tissues were extracted as described previously [51] with little modifications. Fresh samples of luteal tissues (100 mg) were homogenized in ice-cold Tris-buffer (pH 7.4) containing indomethacin (100 lm) using a polytron homogenizer on ice. The homogenate was centrifuged at 50 000 rpm for 1 h at 48C, after which the supernatant (intraluteal lysate) harvested and the concentrations of PGF 2a and PGE 2 in the lysates were assayed by ELISA as described below.
ELISA of PGF 2a , PGE 2 , PGFM, and PGEM
The concentrations of PGF 2a , PGE 2 , PGFM, or PGEM were measured in the plasma of UF, UOV, and OA as well as in luteal tissue extract and CL explant culture medium using commercially available kits (Cayman Chemicals) according to the manufacturer's instructions and as described previously [43, 49, 52] . Intra-and interassay coefficients of variation (CVs) were determined at multiple time points on the standard curve as described by the manufacturer in each assay and compared between assays. For the PGF 2a assay, the sensitivity or minimal detection limit was 3.9 pg/ml; intra-assay CV was 9.4% and interassay CV 12.5%. For the PGE 2 assay, the sensitivity or minimal detection limit was 7.8 pg/ml; intra-assay CV was 4.2% and interassay CV 12.4%. For the PGFM assay, the sensitivity or minimal detection limit was 23 pg/ml; intraassay CV was 6.8% and interassay CV 8.8%. For the PGEM assay, the sensitivity or minimal detection limit was 0.39 pg/ml; intra-assay CV was 5.4% and interassay CV 7.2%.
IFNT Protein Measurement by Western Blot Analysis
For Western blot analysis, UF (2 ll), plasma (2 ll) from UOV or OA, and protein (75 lg) from CL tissue lysates were resolved in 12.5% SDS-PAGE, and Western blot analysis was performed as described previously [46, 47] . The blots were incubated with rabbit polyclonal anti-sheep IFNT antibody (1:5000 dilution) overnight at 48C. The blots were then washed and incubated with goat anti-rabbit IgG conjugated with horse radish peroxidase secondary antibody at 1:10 000 dilution for 1 h at room temperature. Chemiluminescent substrate was applied according to the manufacturer's instructions. The blots were exposed to Blue X-Ray film, and densitometry of autoradiograms was performed using an Alpha Imager.
IFNT Assay by Indirect ELISA
The assay was performed as described previously [53] with little modification. The UF sample was diluted 1:50, and plasma samples from UOV and OA were diluted 1:1 in EIA buffer (1 M phosphate solution containing 1% bovine serum albumin, 4 M sodium chloride, 10 mM EDTA, and 0.1% sodium azide). Standard curves were set up by diluting recombinant ovine IFNT at concentrations from 0 to 500 ng/ml in EIA buffer. On Day 1, the 96-well plate was coated with antigen (50 ll of diluted UF or plasma samples) and incubated at 48C overnight. On Day 2, the unbound antigen in each well was removed, and the wells were washed three times with 200 ll of washing buffer (4 M phosphate solution with 0.05% Tween-20, overall buffer pH 7.4). The remaining protein-binding sites in the coated wells were blocked by 100 ll of blocking buffer (5% nonfat dried milk in Tris-buffered saline with 0.1% Tween-20) and incubated for 2 h at room temperature. The wells were then washed three times with 200 ll of washing buffer. Rabbit anti-sheep polyclonal antibody (100 ll) at 1:5000 dilution in 2% milk was added to each well and incubated overnight at 48C. On Day 3, the wells were washed four times (1 min for each washing) with 200 ll of washing buffer. Horseradish peroxidaseconjugated goat anti-rabbit IgG at 1:2000 in 2% milk was then added to each well and incubated for 2 h at room temperature. The wells were then washed four times (1 min for each washing) with 200 ll of washing buffer. Then, 100 ll of ABTS peroxidase substrate was added, the plate was incubated at room temperature for 1 h and read using an ELISA plate reader (Synergy 4; Bio Tek Instruments, Inc.) at a single wavelength at 405 nm.
Statistical Analyses
Statistical analyses were performed using general linear models of the Statistical Analysis System (SAS Institute, Inc.). Data were checked for normality or homogeneity of variance before analyzing the data statistically. Day (12, 14, or 16) and status (estrous cycle vs. pregnancy) interactions on expression of various proteins were tested using repeated measures for multivariate ANOVA. Comparison of means was tested by Wilks lambda or orthogonal contrast tests. Effects of Day 16 of the estrous cycle or pregnancy on cell-specific expression of various proteins in luteal cells were analyzed using one-way ANOVA. Comparison of means was tested by Tukey honestly significant difference test. Effects of day of estrous cycle or pregnancy on PGF 2a and PGE 2 in UF, UOV, and OA and on PGF 2a , PGFM, PGE 2 , and PGEM in OV and on PGF 2a and PGE 2 levels at various time points in CL explant culture were analyzed using repeated measures for split-plot ANOVA. Numerical data are presented as least squares means 6 SEM. Statistical significance was considered to be P , 0.05. The statistical model accounted for sources of variation, including treatments, replicates, and ewes as appropriate. (Fig. 1B) . PTGS-2 protein was expressed but was not regulated on Days 12-16 of the CY or PX (Fig. 1C) . PTGES-1 protein was expressed on Days 12-16 of the CY and PX. Importantly, its expression was decreased (P , 0.05) on Day 16 of the CY, but it was sustained on Day 16 of PX (Fig.  1D) . PTGES-2 protein was expressed constantly on Days 12-16 of the CY and PX (Fig. 1E) . Expression of PTGES-3 protein was undetectable on Days 12-16 of the CY, but it was highly (P , 0.05) expressed on Days 12-16 of PX (Fig. 1F) . PTGFS-AKR1B1 protein was abundantly expressed on Days 12-16 of the CY and PX; importantly, its expressions was increased (P , 0.05) on Day 16 of the CY compared to that of PX (Fig. 1G) . PTGFS-AKR1C3 protein was expressed without modulation on Days 12-16 of the CY and PX (Fig. 1H) . PGDH protein was not expressed or not delectable on Days 12-16 of the CY; by contrast, its expression was induced (P , 0.05) on Days 12-16 of PX (Fig.  1I) . Our results further indicated that ratio between AKR1B1-PTGFS:PTGES-1 increased (P , 0.05) on Days 14-16 of the CY, whereas ratio between PTGES-1 and AKR1B1-PTGFS increased (P , 0.05) on Days 14-16 of PX (Fig. 1J) . Collectively, these results indicate that luteal PG biosynthetic machinery is selectively directed towards PGF 2a at the time of luteolysis and towards PGE 2 during the establishment of pregnancy in sheep.
RESULTS
Expression and
Expression and Regulation of PGF 2a and PGE 2 Receptors in the CL
We determined temporal regulation of PGF 2a receptor PTGFR and PGE 2 receptors PTGER1, PTGER2, PTGER3, PTGER4, and PGT SLCO2A1 proteins in the CL on Days 12, 14, and 16 of the CY and PX (Fig. 2) . Results indicated that expression of PTGFR protein was not regulated on Days 12-16 by the CY or PX (Fig. 2B) . PTGER1 protein was abundantly expressed on Days 12-14 of the CY and PX, but its expression was decreased (P , 0.05) on Day 16 of PX compared that of the CY (Fig. 2C) . PTGER2 protein was expressed on Days 12-16 of the CY and PX. Importantly, its expression was decreased (P , 0.05) on Day 16 of the CY, but it was sustained on Day 16 of PX (Fig. 2D) . PTGER3 protein was expressed at a very low level on Days 12-16 of the CY, and its expression was marginally increased on Days 12 and 14 of PX (Fig. 2E) . PTGER4 protein was not expressed or undetectable on Days 12-16 of the CY. In contrast, its expression was induced (P , 0.05) on Days 12-16 of PX (Fig. 2F) . SLCO2A1 protein was expressed but not regulated on Days 12-16 of the CY or PX (Fig. 2G) . These results together indicate that luteal PTGER2-and PTGER4-mediated PGE 2 signaling is activated at the time of establishment of pregnancy, whereas it is suppressed at the time of luteolysis in sheep. 
Intraluteal Production of PGF 2a and PGE 2
We determined luteal production and secretion of PGF 2a and PGE 2 and their metabolites PGFM and PGEM, respectively, into ovarian venous blood on Days 14 and 16 of the CY and PX. Results (Fig. 5) indicated that ovarian venous plasma concentrations of PGF 2a were higher (P , 0.05) on Days 14 and 16 of the CY compared to that of PX. Importantly, concentrations of PGE 2 were higher (P , 0.05) on Days 14 and 16 of PX compared to that of the CY. The concentrations of PGFM were higher (P , 0.05) on Days 14 and 16 of PX compared to that of the CY; however, such regulation was not found for PGEM. Our results further indicated that the PGF 2a :PGE 2 ratio was higher (P , 0.05) on Days 14 and 16 of the CY, whereas the PGE 2 :PGF 2a ratio was higher (P , 0.05) on Days 14 and 16 of PX.
In addition, we isolated intraluteal lysates and measured the concentrations of PGF 2a and PGE 2 on Day 16 of the CY and PX. Results (Fig. 6 ) indicated that intraluteal production of PGF 2a was higher (P , 0.05) on Day 16 of the CY, whereas intraluteal PGE 2 production was higher (P , 0.05) on Day 16 of PX. Moreover, PGF 2a :PGE 2 ratio was higher (P , 0.05) on Day 16 of the CY, whereas the PGE 2 :PGF 2a ratio was higher (P , 0.05) on Day 16 of PX.
Furthermore, we conducted CL explant culture in which CL tissue slices were incubated with PGH 2 , and the conversion of PGH 2 into PGF 2a and PGE 2 was measured. Results indicated that luteal tissues from Day 16 of CY (Fig. 7A) had a higher capacity to convert PGH 2 to PGF 2a (P , 0.05), whereas luteal tissues from Day 16 of PX (Fig. 7B) had a higher capacity to convert PGH2 to PGE 2 (P , 0.05) in a dose-dependent LUTEAL PGF 2a AND PGE 2 BIOSYNTHESIS AND SIGNALING gravid uterus; these factors need to be transported from the gravid uterus to the ovary through the UOP. As detailed in the Introduction, the potential candidates are IFNT, PGE 2 , and PGF 2a .
We first determined the transport of the conceptus-derived factor IFNT from the uterus to the ovary. Western blot analyses (Fig. 8, A and B) indicated that IFNT protein was abundant (P , 0.05) in UF on Days 12, 14, and 16 of PX but was not detectable in UF of the CY. IFNT protein was not detectable (P , 0.05) in the UO, OA, and CL on Days 12, 14, and 16 of PX and CY. To confirm this observation, we measured IFNT protein using the more sensitive and quantitative ELISA. Results (Fig. 8, C-H) indicated that IFNT protein was abundant (P , 0.05) in UF but not detectable (P , 0.05) in UOV and OA on Days 12, 14, and 16 of PX. As expected, IFNT protein was not detectable (P , 0.05) in UF, UOV, and OA on Days of 12, 14, and 16 of the CY. These quantitative and qualitative analyses indicate that the IFNT protein is not transported from the uterus to the CL through the UOP during the establishment of pregnancy in sheep.
Next, we determined transport of PGE 2 and PGF 2a from the gravid uterus to the CL. Results (Fig. 9) 2 :PGF 2a ratio in the UOV was approximately 72-fold higher (P , 0.05), and in the OA was approximately 115-fold higher (P , 0.05), on Day 16 of PX versus CY. These results indicate that PGE 2 is more efficiently transported from the uterus to the ovary through the UOV and the OA during the establishment of pregnancy. In contrast, PGF 2a is preferentially transported at the time of luteolysis.
DISCUSSION
In ruminants, PGF 2a is the luteolytic hormone, whereas PGE 2 is considered to be a luteoprotective mediator [8, 9] . Endometrial PGF 2a causes functional luteolysis, but luteal PGF 2a is necessary for structural luteolysis. During early pregnancy, PGE 2 produced by the CL in response to endometrial PGE 2 may counteract the luteolytic effect of both exogenous and endogenous PGF 2a . However, the underlying molecular and cellular mechanisms of luteal PGF 2a and PGE 2 biosynthesis, catabolism, and signaling are largely unknown.
The present results indicate that the ratio between PTGFS-AKR1B1 and PTGES-1 or PTGES-3 is higher on Days 14-16 of the estrous cycle. In contrast, the ratio between PTGES-1 or PTGES-3 and PTGFS-AKR1B1 is higher on Days 14-16 of pregnancy. To evaluate the functional aspects of these enzymatic changes, we measured luteal production and secretion of PGF 2a and PGE 2 . The ratio of PGF 2a to PGE 2 in ovarian venous plasma is higher on Days 14 and 16 of the estrous cycle, whereas the ratio of PGE 2 to PGF 2a is higher on Days 14 and 16 of pregnancy. Analyses of luteal lysates indicate that intraluteal production of PGF 2a is higher on Day 16 of the estrous cycle; in contrast, intraluteal PGE 2 production is increased on Day 16 of pregnancy. Data from CL explant cultures indicate that luteal tissues from Day 16 of the estrous cycle selectively convert PGH 2 to PGF 2a , whereas luteal tissues from Day 16 of pregnancy selectively convert PGH 2 to LEE ET AL. PGE 2 . Collectively, these results indicate that luteal PG biosynthesis is selectively directed towards PGF 2a at the time of luteolysis and towards PGE 2 during the establishment of pregnancy. The present results support previous findings that PTGES-1 protein is highly expressed in the CL at the time of establishment of pregnancy in cows [46] and that the ratio of PTGES-1 to PTGFS-AKR1B1 mRNA is increased in luteal tissue on Day 12 of pregnancy compared to that of the estrous cycle in sheep [54] . Earlier studies reported that the administration of PGF 2a on Day 11 or 12 of the estrous cycle induced expression of PTGS-2 mRNA in luteal tissues at 1-4 h, but it returned to basal levels at 12 and 24 h in sheep [50] . The present data indicate that PTGS-2 protein is constantly expressed in CL on Days 12-16 of the estrous cycle and pregnancy. Expression of PTGS-2 is required for both PGF 2a and PGE 2 biosynthesis. PTGES-1 is functionally coupled to PTGS-2 and controls more than 90% of total PGE 2 production. PTGES-2 is preferentially coupled to constitutive PTGS-1. PTGES-3 is coupled to both PTGS-1 and PTGS-2 under different physiological circumstances [55, 56] . The present results indicate that the PTGS-2 and PTGFS-AKR1B1 pathway is involved in luteal PGF 2a biosynthesis at the time of luteolysis and that the PTGS2 and PTGES-1/PTGES-3 pathway is involved in luteal PGE 2 biosynthesis during the establishment of pregnancy.
The net luteal production of PGF 2a versus PGE 2 is not only regulated by biosynthetic enzymes PTGS-2, PTGFS-AKR1B1, PTGES-1, or PTGES-3 but also by the catabolic enzyme PGDH. Our results indicate that the PGDH protein is highly expressed on Days 12-16 of pregnancy but not expressed on Days 12-16 of the estrous cycle in sheep. To determine the functional aspects of luteal PGDH in vivo, we measured the concentrations of PGFM and PGEM in ovarian venous plasma. The concentrations of PGFM are higher on Days 14 and 16 of pregnancy compared to that of the estrous cycle. Surprisingly, the concentration of PGEM is very low and does not appear to be regulated. Three isoforms of PGDH are identified. These PGDH isoforms are differentially expressed in human placental tissues [57] , and their functions are not completely understood. The action of PGDH on PGF 2a catabolism is well supported in the ovine CL [58] . However, PGDH action on PGE 2 catabolism is largely unknown. Our result suggests that the PGDH protein detected at 29 kDa in the ovine CL catabolizes only PGF 2a into PGFM, and not PGE 2 into PGEM, during early pregnancy. We believe that other PGDH isoforms that are yet to be characterized or discovered may control the catabolism of PGE 2 to PGEM in the ovine CL. Our present results support previous findings that PGDH mRNA expression is increased in the CL on Days 13-14 of pregnancy compared to that of the estrous cycle in sheep and that this increase is critical for catabolism of PGF 2a by the CL of early pregnancy [58] . Collectively, these results indicate that intraluteal PGF 2a production at the time of luteolysis is governed by an increase in the ratio of PTGFS-AKR1B1 to PTGES-1 and PTGES-3, whereas the increased intraluteal PGE 2 production during the establishment of pregnancy is governed by an increase in the ratio of PTGES-1 and PTGES-3 to PTGFS-AKR1B1 plus increased PGF 2a catabolism by PGDH.
Both PGF 2a and PGE 2 synthesized within the CL need to be transported out of luteal cells and act through their specific receptors, PTGFR or PTGER, respectively, to produce their physiological effects. SLCO2A1 competitively transports PGF 2a and PGE 2 with equal affinity [59] . The present results indicate that expression of SLCO2A1 protein in the CL is not regulated on Days 12-16 by the estrous cycle or pregnancy. This constant expression of SLCO2A1 suggests that the SLCO2A1 protein is readily available to transport PGF 2a or PGE 2 from luteal cells.
The present results also indicate that the expression of the FP protein in the CL on Days 12-16 is not regulated by the estrous cycle or pregnancy. It has been shown that parenteral administration of PGF 2a decreased PTGFR mRNA within 12-24 h on Days 10-14 of the estrous cycle in sheep [60, 61] . Activation of FP in turn activates PKC, inositol 1,4,5-triphosphate (IP3), and Ca2 þ cell signaling pathways [4] and interacts with multiple intracellular cell signaling pathways in the luteal cells in sheep and cows [13, 62, 63] . The present results support the previous findings that PTGFR numbers or PTGFR mRNA in the CL are similar in cyclic and early pregnant sheep and that the resistance of the CL of early pregnancy to exogenous PGF 2a is apparently not due to a change in PTGFR receptor numbers/concentration [64] .
In addition, our results indicate that luteal PTGER2-and PTGER4-mediated PGE 2 signaling is activated during the establishment of pregnancy, whereas it is suppressed at the time of luteolysis. PTGER2 and PTGER4 activate cAMP and PKA pathways and transactivates ERK1/2, AKT, NFjB, and CTNNB1 pathways in multiple cell types [5] [6] [7] , which in turn activates cell survival pathways and suppresses apoptotic pathways. Thus, activation of PTGER2 and PTGER4 may be one of the critical mechanisms protecting the CL from luteolytic challenges during early pregnancy in sheep. Our future studies will determine the direct interactions between the effects of PTGER2/PTGER4 on luteal cell survival and resistance of the CL of early pregnancy to PGF 2a .
Expression of PTGER3 protein is marginally increased on Days 12 and 14 of pregnancy compared to that of the estrous cycle. Four PTGER3 isoforms (PTGER3A through PTGER3D) are produced by alternative splicing of the Cterminal. Each PTGER3 isoform showed different efficiency in activation of the G q , G s , and G i proteins as well as inhibition or stimulation of adenylate cyclase and cAMP [4] . Activation of PTGER3A decreases cAMP, PTGER3B and PTGER3C increases cAMP, and PTGER3D decreases cAMP and increases IP3 [4] . The commercially available PTGER3 antibody used in the present study recognized N-terminal but not C-terminal splices. Thus, specific PTGER3 isoforms were not detectable in the present study. However, a recent study in cows showed that expression of PTGER3B mRNA increased in the CL in response to PGE 2 , which was associated with maintenance of the CL [65] . It is possible that PTGER2, PTGER4, and PTGER3B could activate or share the common cAMP-PAK intracellular pathways in the ovine CL. However, this possibility is yet to be examined by receptor-specific functional studies. The present results also show that expression of EP1 protein in the CL is decreased on Day 16 of pregnancy. Stimulation of PTGER1 is known to activate PKC, IP3, and Ca2 þ cell signaling pathways [4] . The observed decrease in expression of PTGER1 protein on Day 16 of pregnancy in the CL suggests that luteal PGE 2 signaling is specifically directed towards the cAMP-PKA pathways through PTGER2, PTGER4, and PTGER3B subtypes during the establishment of pregnancy in sheep.
Infusion of IFNT into a uterine vein of sheep maintains a functional CL in 80% of treated animals for up to 32 days through as-yet-unidentified mechanisms [33, 34] . Our current finding that IFNT protein is not present in uterine venous blood and in the CL on Days 14-16 of pregnancy in sheep is contrary to the recent reports by Bott et al. [33] and Oliveira et al. [34] , who reported high levels of IFNT in uterine venous blood on Day 15 of pregnancy in sheep. The reason for this discrepancy is most likely the methodology used. Earlier pioneering work LUTEAL PGF 2a AND PGE 2 BIOSYNTHESIS AND SIGNALING by Godkin et al. [66] indicated that intrauterine infusion of 125 Ilabeled ovine trophoblast protein-1 (oTP-1, later named IFNT [66] . Moreover, IFNT is a relatively large protein (19 kDa), and it could not be transferred locally to the ovary via the UOP. Our present quantitative (ELISA) and qualitative (Western blot) analyses confirm that IFNT protein is not transported from the uterus to the CL through the UOP at the time of establishment of pregnancy in sheep, which is in agreement with the earlier pioneering study by Godkin et al. [66] . Furthermore, embryo/conceptus transfer and hysterectomy experiments indicate that the luteolytic and luteoprotective mechanisms are locally mediated between the uterus and the CL of the ipsilateral ovary and do not act systemically in sheep [38] [39] [40] . This local action of the embryonic antiluteolytic/ luteoprotective factor effectively precludes any direct action of a protein transported systemically from the gravid uterus to the CL in ruminants [21] . Several authors [34, [67] [68] [69] [70] have reported an increase in IFN-stimulated genes in peripheral tissues (leukocytes, liver, and CL) of pregnant sheep and cows. However, because of the established local effect between the uterus and the CL in early pregnancy, the above-reported systemic effects on peripheral expression of interferonstimulated genes appeared not to be critical for establishment of pregnancy. Given the facts discussed above, the reports by Bott et al. [33] and Oliveira et al. [34] on the release of IFNT from the uterus to the uterine vein at the time of establishment of pregnancy in sheep are still controversial; however, these studies open up a new area of research. Thus, further work will be required to determine the physiological significance of uterine vein infusions of recombinant ovine IFNT and the possible mechanisms by which such parenteral administrations of IFNT may affect luteal function in sheep.
The concentrations of both PGE 2 and PGF 2a are increased in the uterine venous plasma at the time of establishment of pregnancy in sheep [10, 20, 21, 27, [71] [72] [73] [74] . Therefore, we measured the transport of PGF 2a and PGE 2 from the uterus to the ovary through the UOP on Days 12-16 of the estrous cycle and pregnancy. Our results indicate that PGF 2a is preferentially transported at the time of luteolysis from the uterus to the ovary. By contrast PGE 2 is preferentially transported at the time of establishment of pregnancy from the uterus to the ovary. Moreover, the PGE 2 :PGF 2a ratio is 72-fold higher in the UOV and 115-fold higher in the OA on Day 16 of pregnancy compared to that of the estrous cycle. Our present data are in agreement with several previous findings that the secretion of PGE 2 from the uterus into the UOV increases during the period of luteal resistance in early pregnancy in sheep [20, 21, 27, [71] [72] [73] [74] [75] . PGE 2 is a lipid-soluble mediator with a small molecular weight of 0.35 kDa, is structurally similar to PGF 2a , and can be easily transported locally from the uterus to the ovary [21] through PGT-mediated mechanisms in the UOP [52, 59] and, thus, exert a luteoprotective effect through multiple mechanisms.
The intrauterine concentration of PGF 2a is significantly higher compared to that of PGE 2 on Day 16 of the estrous cycle and pregnancy. Importantly, approximately 85% of PGF 2a is transported from the uterus to the UOV at the time of luteolysis, whereas only approximately 35% of PGF 2a is transported from the uterus to the UOV at the time of establishment of pregnancy. This observation suggests that PGF 2a is secreted/transported from the endometrium to the UOV (endocrine secretion) at the time of luteolysis and from the endometrium to the uterine lumen (exocrine secretion) at the time of establishment of pregnancy in ruminants, as has been proposed in pigs [76] . Transport of PGE 2 from the uterus to the UOV and from the UOV to the OA appears to depend on the net concentration of PGE 2 in the uterine lumen and the UOV, respectively. These results suggest that PGE 2 is transported from the uterus to the ovary selectively or preferentially and is not regulated by endocrine-exocrine secretory mechanisms at the time of luteolysis and establishment of pregnancy in sheep. It is possible that SLCO2A1 [43, 49, 59] , either individually or in coordination with other transporters, such as ATP-binding cassette subfamily C member 4 (ABCC4, also known as MRP4) [77] , could regulate this endocrine versus exocrine transport of PGF 2a and the preferential or selective transport of PGE 2 in ruminant endometrium. The current understanding of PG transport mechanisms is not enough to explain the selective transport of PGE 2 and PGF 2a from the uterus to the ovary in ruminants. Thus, more functional studies are needed to understand this complex and important mechanism.
In summary, the results of the present study indicate that 1) luteal PG biosynthesis is selectively directed towards PGF 2a at the time of luteolysis and towards PGE 2 during the establishment of pregnancy, 2) the ability of the CL of early pregnancy to resist luteolysis is likely due to increased intraluteal biosynthesis of PGE 2 and PTGER2 and PTGER4 signaling, 3) IFNT protein is not transported from the uterus to the CL/ovary through the UOP, 4) a large proportion of endometrial PGE 2 is transported from the uterus to the CL/ ovary through the UOP, and 5) endometrial PGE 2 stimulated by pregnancy appears to increase luteal PGE 2 biosynthesis and, hence, activate PTGER2-and PTGER4-mediated intracellular mechanisms, thus rescuing and protecting the CL during the establishment of pregnancy in sheep/ruminants. The underlying mechanisms that regulate selective luteal PGE 2 biosynthesis and signaling during the establishment of pregnancy are not presently known. Our future studies will investigate these proposed direct interactions among IFNT, endometrial/conceptus-derived PGE 2 , luteal PGE 2 biosynthesis, and luteal PTGER2 and PTGER4 signaling as well as their effects on the survival/resistance of the CL of early pregnancy.
